» Authors » Jeremy N Ruskin

Jeremy N Ruskin

Explore the profile of Jeremy N Ruskin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 222
Citations 6189
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nahlawi A, Ptaszek L, Ruskin J
Nat Cardiovasc Res . 2025 Feb; 4(2):131-144. PMID: 39910289
Psychedelics, used for millennia in spiritual and healing practices, have emerged as promising treatments for mental health conditions including depression, post-traumatic stress disorder (PTSD), substance use disorders and anxiety. Despite...
2.
Ghaznavi S, Ruskin J, Haggerty S, King 4th F, Rosenbaum J
Am J Psychiatry . 2025 Jan; 182(1):47-53. PMID: 39741443
The last few years have seen exponential growth in interest, investment, advocacy, and research into psychedelics as therapeutics. This reflects an optimism about the potential promise of psychedelics as therapeutics....
3.
Daoudi S, John K, Chalhoub F, Chee J, Infeld M, Elbaz-Greener G, et al.
J Clin Med . 2024 Aug; 13(16). PMID: 39201025
: Atrial fibrillation (AF) and flutter (AFL) are the most common cardiac arrhythmias worldwide. Cardiovascular complications are a common manifestation of acute and post-acute COVID-19 infection. We aimed to analyze...
4.
Ruskin J, Camm A, Dufton C, Woite-Silva A, Tuininga Y, Badings E, et al.
JACC Clin Electrophysiol . 2024 Apr; 10(6):1021-1033. PMID: 38613545
Background: INSTANT (INhalation of flecainide to convert recent-onset SympTomatic Atrial fibrillatioN to sinus rhyThm) was a multicenter, open-label, single-arm study of flecainide acetate oral inhalation solution (FlecIH) for acute conversion...
5.
Khaloo P, Ledesma P, Nahlawi A, Galvin J, Ptaszek L, Ruskin J
J Am Heart Assoc . 2023 Sep; 12(18):e030114. PMID: 37681546
Background Takotsubo syndrome (TS) and myocardial infarction (MI) share similar clinical and laboratory characteristics but have important differences in causes, demographics, management, and outcomes. Methods and Results In this observational...
6.
Margolis G, Hamuda N, Kobo O, Greener G, Amir O, Homoud M, et al.
J Am Heart Assoc . 2023 Jul; 12(15):e029126. PMID: 37522389
Background Routine addition of an atrial lead during an implantable cardioverter-defibrillator (ICD) implantation for primary prevention of sudden cardiac death, in patients without pacing indications, was not shown beneficial in...
7.
Khaloo P, Uzomah U, Shaqdan A, Ledesma P, Galvin J, Ptaszek L, et al.
J Am Heart Assoc . 2022 Aug; 11(17):e025600. PMID: 36000421
Background Most published reports describing outcomes of patients with cardiovascular implantable electronic device-related infective endocarditis (CIED-IE) are single-center studies with small patient sample sizes. The goal of this study was...
8.
Rozen G, Elbaz-Greener G, Margolis G, Marai I, Heist E, Ruskin J, et al.
J Clin Med . 2022 Mar; 11(6). PMID: 35330003
Background: Obesity has been associated with increased incidence and severity of various cardiovascular risk factors and increased risk for stroke. However, the evidence of its effect on outcomes in stroke...
9.
Rozen G, Elbaz-Greener G, Andria N, Heist K, Ruskin J, Roguin A, et al.
J Cardiovasc Electrophysiol . 2022 Mar; 33(6):1128-1135. PMID: 35304926
Background: Catheter ablation (CA) for atrial fibrillation (AF) is increasingly utilized in recent years, with promising results. We aimed to investigate the nationwide trends in utilization and procedural complications of...
10.
Margolis G, Elbaz-Greener G, Ruskin J, Roguin A, Amir O, Rozen G
Curr Cardiol Rep . 2022 Mar; 24(5):497-504. PMID: 35230617
Purpose Of Review: We aimed to describe the epidemiology of sudden cardiac death (SCD) in the obese, elaborating on the potential pathophysiological mechanisms linking obesity, SCD, and the outcomes in...